Requires the Health and Human Services Agency to assemble a working group with the intent that they offer policy recommendations on a legal framework for the regulated use of hallucinogenic and psychedelic-assisted therapy, which is the use of controlled substances for treatment to counsel, administered and facilitated by a "licensed professional" in a clinical setting.
Requires the Health and Human Services Agency to assemble a working group with the intent that they offer policy recommendations on a legal framework for the regulated use of hallucinogenic and psychedelic-assisted therapy, which is the use of controlled substances for treatment to counsel, administered and facilitated by a "licensed professional" in a clinical setting.
